These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25031058)

  • 1. Risk factors associated with the occurrence of adverse events in plateletpheresis donation.
    Barbosa MH; da Silva KF; Coelho DQ; Tavares JL; da Cruz LF; Kanda MH
    Rev Bras Hematol Hemoter; 2014; 36(3):191-5. PubMed ID: 25031058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Indications and Adverse Reactions of Platelet Apheresis.
    Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
    Patidar GK; Sharma RR; Marwaha N
    Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and severity of adverse events among platelet donors: A three-year retrospective study.
    Almutairi H; Salam M; Batarfi K; Alharbi D; Wani F; Almutairi A; Al-Shammari B; Al-Surimi K
    Medicine (Baltimore); 2020 Dec; 99(52):e23648. PubMed ID: 33350744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of adverse reactions in plateletpheresis donors with the perspective of donor safety in a tertiary care hospital of Northern India.
    Solanki A; Katharia R; Singh A; Chauhan A; Chandra T; Sonker A; Agarwal P
    Asian J Transfus Sci; 2020; 14(1):44-48. PubMed ID: 33162705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
    Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
    Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program.
    Despotis GJ; Goodnough LT; Dynis M; Baorto D; Spitznagel E
    Vox Sang; 1999; 77(1):24-32. PubMed ID: 10474087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of plateletpheresis on total platelet count and mean platelet volume: A meta-analysis.
    Gil-Betancur A; Mantilla-Gutierrez CY; Cardona-Arias JA
    J Evid Based Med; 2020 Aug; 13(3):206-214. PubMed ID: 32615026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
    Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
    Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety.
    Gupta AM; Bajpai M
    J Clin Apher; 2020 Jan; 35(1):18-24. PubMed ID: 31663633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostatic parameters, platelet activation markers, and platelet indices among regular plateletpheresis donors.
    Tuan HTM; Hock LS; Abdullah ZW
    J Taibah Univ Med Sci; 2018 Apr; 13(2):180-187. PubMed ID: 31435321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of applying the 2day deferral for repeat plateletpheresis: Indian perspective.
    Nomani L; Raina TR; Sidhu M
    Transfus Apher Sci; 2013 Jun; 48(3):341-3. PubMed ID: 23643473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
    Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
    Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations.
    Lazarus EF; Browning J; Norman J; Oblitas J; Leitman SF
    Transfusion; 2001 Jun; 41(6):756-61. PubMed ID: 11399815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alarmed or unalarmed!! Donor red cell lysis during plateletpheresis procedure.
    Kaur D; Kandwal M
    Transfus Apher Sci; 2018 Apr; 57(2):277-280. PubMed ID: 29610044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.
    Arora D; Garg K; Kaushik A; Sharma R; Rawat DS; Mandal AK
    J Clin Diagn Res; 2016 Nov; 10(11):EC22-EC24. PubMed ID: 28050376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.
    Crocco I; Franchini M; Garozzo G; Gandini AR; Gandini G; Bonomo P; Aprili G
    Blood Transfus; 2009 Jan; 7(1):35-8. PubMed ID: 19290078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of Platelet Count among Apheresis Platelet Donors.
    Thokala RP; Radhakrishnan K; Anandan A; Panicker VK
    J Clin Diagn Res; 2016 Dec; 10(12):EC01-EC04. PubMed ID: 28208861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of reticulated platelets in response to whole blood donation or plateletpheresis.
    Gyongyossy-Issa MI; Miranda J; Devine DV
    Transfusion; 2001 Oct; 41(10):1234-40. PubMed ID: 11606821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.